Used in pharmaceutical research as a key intermediate for kinase inhibitors, particularly in the development of targeted cancer therapies. Shows activity in modulating signaling pathways involved in tumor growth and proliferation. Investigated for potential use in treating hematological malignancies and solid tumors due to its ability to selectively inhibit specific tyrosine kinases. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and metabolic stability.